Dr. John Bilezikian
Dr. Bilezikian, the Dorothy L. and Daniel H. Silberberg Professor of Medicine and Professor of Pharmacology at the College of Physicians & Surgeons, Columbia University is Chief of the Division of Endocrinology and Director of the Metabolic Bone Diseases Program at Columbia University Medical Center. Dr. Bilezikian received his undergraduate training at Harvard College and his medical training at the College of Physicians & Surgeons. He completed four years of house staff training (internship, residency and Chief Residency) on the Medical Service at Columbia Presbyterian Medical Center. Dr. Bilezikian received his training in Metabolic Bone Diseases and in Endocrinology at the NIH in the Mineral Metabolism Branch under the tutelage of Dr. Gerald Aurbach.
Dr. Bilezikian belongs to a number of professional societies including the American Society for Bone and Mineral Research, of which he served as President, 1995-1996 and the International Society of Clinical Densitometry, of which he served as President, 1999-2001. He is a member of the Endocrine Society, the American Federation for Clinical Research, the American Society for Clinical Investigation, the Association of American Physicians, the American Association of Clinical Endocrinologists, the American Society for Pharmacology and Experimental Therapeutics, and the American College of Endocrinology that has designated him Master. He is Chair of the Endocrine Fellows Foundation. He served as Editor-in-Chief of the Journal of Clinical Endocrinology and Metabolism (2000-2004). He is Senior Associate Editor of the Journal of Bone and Mineral Research (2008- ). His books include Editor-in-Chief of The Parathyroids (1994, 2001), and co-editor of The Aging Skeleton (1999), Dynamics of Bone and Cartilage Metabolism (1999, 2006), and Principles of Bone Biology (1996, 2002, 2008) and Osteoporosis in Men (2010).
He has been on numerous panels, including serving as Chair of the NIH Consensus Development Panel on Optimal Calcium Intake (1994) and Co-chair of the last two NIH Workshops on Primary Hyperparathyroidism (2002, 2008). He is a major national and international spokesperson for the field of metabolic bone diseases. Dr. Bilezikian’s major research interests are related to the clinical investigation of metabolic bone diseases, particularly osteoporosis and primary hyperparathyroidism. He is the recipient of the Distinguished Physician Award of the Endocrine Society, the Frederic C. Bartter Award of the American Society for Bone and Mineral Research (ASBMR) for Excellence in Clinical Research, the John P. McGovern Compleat Physician Award of the Houston Academy of Medicine, the First Annual Global Leadership Award of the International Society of Clinical Densitometry, and Lifetime Achievement Awards of the Armenian American Medical Society of California and the Armenian American Health Professionals Organization. In 2009, he received the Gideon A. Rodan Excellence in Mentorship Award from the ASBMR. His publications, which number over 600, speak to his active original investigative initiatives as well as his authorship of many reference sources of endocrinology and metabolic bone diseases.